Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Cash from Operations over the past 9 years, most recently at 6008000.0 for Q4 2023.

  • For Q4 2023, Cash from Operations rose 19.41% year-over-year to 6008000.0; the TTM value through Dec 2023 reached 36100000.0, up 3.85%, while the annual FY2024 figure was 41794000.0, 15.77% down from the prior year.
  • Cash from Operations for Q4 2023 was 6008000.0 at Corbus Pharmaceuticals Holdings, up from 7176000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 10318298.0 in Q1 2019 and troughed at 27601162.0 in Q1 2020.
  • A 5-year average of 13361728.15 and a median of 13672013.0 in 2022 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 745.17% in 2019 and later plummeted 945.44% in 2022.
  • Year by year, Cash from Operations stood at 22561865.0 in 2019, then increased by 19.23% to 18224308.0 in 2020, then soared by 46.76% to 9702575.0 in 2021, then grew by 23.16% to 7454985.0 in 2022, then grew by 19.41% to 6008000.0 in 2023.
  • Business Quant data shows Cash from Operations for CRBP at 6008000.0 in Q4 2023, 7176000.0 in Q3 2023, and 7801028.0 in Q2 2023.